A retinal imaging platform that uses artificial intelligence to evaluate eye scans for biomarkers of Alzheimer’s disease and other neurological disorders has received the FDA’s “Breakthrough Device” ...
Spectral-domain optical coherence tomography (OCT) is the gold standard for diagnosing retinal diseases such as macular degeneration and diabetic retinopathy, as well as glaucoma. OCT is particularly ...
Since the beginning of the month, the FDA has granted several artificial intelligence-powered health IT products “Breakthrough Device” status, which does not indicate safety approval, but designates a ...
ED: WHEN AN INTERNATIONAL COMPANY BASED IN SCOTLAND WANTED TO BUILD THE WORLD’S BEST EYE IMAGING MACHINE, WHERE ELSE DID THEY LOOK? MARIA: RIGHT HERE TO MASSACHUSETTS. NOT ONLY ARE THEY HELPING WITH ...
The burden of Alzheimer’s disease (AD) goes far beyond the afflicted patient, affecting family, friends, and a significant portion of the healthcare system. Currently, there are more than 5 million ...
The two are reportedly discussing what the ‘new hardware for the AI age could look like.’ Altman recently worked with Ive protégé Thomas Meyerhoffer to develop the Orb retina scanner. The two are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results